ALDX - Aldeyra Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents3,357.4722,023.33712,015.06114,648.866
Short Term Investments46,242.2222,923.46212,897.58412,941.776
Net Receivables44,00018,000--
Inventory----
Other Current Assets----
Total Current Assets94,769.28643,965.76625,131.32728,088.194
Long Term Investments----
Property Plant and Equipment235.22543.26256.35280.334
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets86.644165.93-36.236
Deferred Long Term Asset Charges----
Total Assets95,091.15544,174.95825,187.67928,204.764
Current Liabilities
Accounts Payable3,051.6781,000.963275.441851.16
Short/Current Long Term Debt-116.31977.54677.546
Other Current Liabilities----
Total Current Liabilities8,473.1763,353.7472,299.2382,115.135
Long Term Debt-1,220.1921,238.6241,211.31
Other Liabilities----
Deferred Long Term Liability Charges86.644165.93-36.236
Minority Interest----
Negative Goodwill----
Total Liabilities8,473.1764,573.9393,537.8623,326.445
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock26.24419.13812.5769.713
Retained Earnings-138,535.168-99,641.923-77,301.334-58,601.884
Treasury Stock-9.224-17.8310.129-8.361
Capital Surplus225,136.127139,241.63598,938.44683,478.851
Other Stockholder Equity-9.224-17.8310.129-8.361
Total Stockholder Equity86,617.97939,601.01921,649.81724,878.319
Net Tangible Assets86,617.97939,601.01921,649.81724,878.319